期刊
JOURNAL OF HEART AND LUNG TRANSPLANTATION
卷 29, 期 5, 页码 574-577出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2009.10.006
关键词
HLHS; heart failure; autologous stem cell therapy
资金
- Deutsche Forschungsgemeinschaft [Exc 147/1]
Novel surgical strategies have dramatically improved the initial outcome of newborns with hypoplastic left heart syndrome. However, the single systemic right ventricle remains a major challenge, with limited effectiveness of pharmacologic therapy. The present case documents that the intracoronary administration of autologous bone marrow-derived progenitor cells is technically feasible in a critically ill infant with hypoplastic left heart syndrome and severe heart failure after a hybrid comprehensive stage II procedure. Cell therapy might represent an option before heart transplantation in children with single ventricle physiology presenting with severe heart failure. J Heart Lung Transplant 2010;29:574-577 (C) 2010 International Society for Heart and Lung Transplantation. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据